SRNE

Sorrento Therapeutics Stock Price

12.32
-0.69 (-5.3%)
Upgrade to Real-Time
Afterhours (Closed)
12.32
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.69 -5.3% 12.32 00:00:00
Close Price Low Price High Price Open Price Previous Close
12.44 11.70 12.60 12.50 13.01
Bid Price Ask Price Spread News
10.50 13.60 3.10 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
126,345 38,193,422 $ 12.37 $ 472,489,487 37,660,473 1.39 - 21.26
Last Trade Time Type Quantity Stock Price Currency
19:59:59 formt 300 $ 12.32 USD

Sorrento Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.98B 242.03M 237.22M $ 31.43M $ - -2.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sorrento Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SRNE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week13.1221.2610.6014.73119,329,252-0.80-6.1%
1 Month6.7321.266.620112.6564,850,0645.5983.06%
3 Months5.0821.263.829.6039,268,4897.24142.52%
6 Months2.8121.261.557.8229,620,4289.51338.43%
1 Year2.1121.261.397.2716,763,24110.21483.89%
3 Years1.7521.261.396.856,980,79610.57604.0%
5 Years14.7621.261.396.784,372,580-2.44-16.53%

Sorrento Therapeutics Description

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody drug conjugates.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.